
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.5M | $1.1M | $28.1M | $59.3M | $89.8M | |
Revenue Growth (YoY) | 875.65% | -25.34% | 2482.37% | 111.06% | 51.4% | |
Cost of Revenues | $1.4M | $1.1M | $25.2M | $54.3M | $79.6M | |
Gross Profit | $101.4K | $37.8K | $2.9M | $5M | $10.2M | |
Gross Profit Margin | 6.96% | 3.47% | 10.2% | 8.46% | 11.38% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $3.4M | $5.5M | $10.4M | $7.4M | $12.2M | |
Other Inc / (Exp) | $2.5M | -$881.7K | -$12.7M | -$400.8K | -$8.1M | |
Operating Expenses | $4.9M | $7M | $13.3M | $11.4M | $23.6M | |
Operating Income | -$4.8M | -$6.9M | -$10.4M | -$6.3M | -$13.4M | |
Net Interest Expenses | $50.8K | $498.3K | $1.5M | $4M | $4.8M | |
EBT. Incl. Unusual Items | -$2.4M | -$8.3M | -$24.7M | -$10.7M | -$26.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $467K | -$1.1M | -$4.4M | $92.7K | $126.9K | |
Net Income to Company | -$2.9M | -$7.3M | -$20.2M | -$10.8M | -$26.4M | |
Minority Interest in Earnings | $687.7K | $1.8M | $809.2K | $96.7K | $4.2M | |
Net Income to Common Excl Extra Items | -$2.2M | -$5.5M | -$19.4M | -$10.7M | -$22.2M | |
Basic EPS (Cont. Ops) | -$0.23 | -$0.46 | -$1.22 | -$0.56 | -$0.76 | |
Diluted EPS (Cont. Ops) | -$0.23 | -$0.46 | -$1.22 | -$0.56 | -$0.76 | |
Weighted Average Basic Share | $10.3M | $12M | $16M | $19.3M | $30.5M | |
Weighted Average Diluted Share | $10.3M | $12M | $16M | $19.3M | $30.5M | |
EBITDA | -$755.6K | -$6.3M | -$20.2M | -$2.8M | -$10M | |
EBIT | -$2.3M | -$7.8M | -$23.2M | -$6.7M | -$21.4M | |
Revenue (Reported) | $1.5M | $1.1M | $28.1M | $59.3M | $89.8M | |
Operating Income (Reported) | -$4.8M | -$6.9M | -$10.4M | -$6.3M | -$13.4M | |
Operating Income (Adjusted) | -$2.3M | -$7.8M | -$23.2M | -$6.7M | -$21.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $95K | -- | $15.5M | $16M | $37.3M | |
Revenue Growth (YoY) | -- | -- | -- | 3.07% | 133.07% | |
Cost of Revenues | $91.9K | -- | $14M | $15M | $32.6M | |
Gross Profit | $3.1K | -- | $1.5M | $1.1M | $4.8M | |
Gross Profit Margin | 3.24% | -- | 9.73% | 6.67% | 12.74% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.8M | $1.5M | $1.9M | $1.7M | $5.4M | |
Other Inc / (Exp) | $12.7M | $1.2M | -$485.8K | $148.9K | $67.4K | |
Operating Expenses | $2.1M | $1.9M | $2.6M | $2.7M | $11.2M | |
Operating Income | -$2.1M | -$1.9M | -$1.1M | -$1.6M | -$6.4M | |
Net Interest Expenses | $152.8K | $85.6K | $1.2M | $441.7K | $1.2M | |
EBT. Incl. Unusual Items | $10.4M | -$725.2K | -$2.8M | -$1.9M | -$7.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1M | $800 | $800 | $800 | -- | |
Net Income to Company | $9.4M | -$726K | -$2.8M | -$1.9M | -$7.5M | |
Minority Interest in Earnings | $141.8K | $125.2K | $282.6K | $28.3K | $6.5K | |
Net Income to Common Excl Extra Items | $9.5M | -$600.9K | -$2.5M | -$1.9M | -$7.5M | |
Basic EPS (Cont. Ops) | $0.84 | -$0.04 | -$0.14 | -$0.07 | -$0.21 | |
Diluted EPS (Cont. Ops) | $0.73 | -$0.04 | -$0.14 | -$0.07 | -$0.21 | |
Weighted Average Basic Share | $11.3M | $13.7M | $18.1M | $26.4M | $43.1M | |
Weighted Average Diluted Share | $13.1M | $13.7M | $18.1M | $26.4M | $43.1M | |
EBITDA | $10.9M | -$258.1K | -$826.2K | -$456.7K | -$518K | |
EBIT | $10.5M | -$633.3K | -$1.6M | -$1.5M | -$6.3M | |
Revenue (Reported) | $95K | -- | $15.5M | $16M | $37.3M | |
Operating Income (Reported) | -$2.1M | -$1.9M | -$1.1M | -$1.6M | -$6.4M | |
Operating Income (Adjusted) | $10.5M | -$633.3K | -$1.6M | -$1.5M | -$6.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $59.8M | $111.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | $55.2M | $97.2M | |
Gross Profit | -- | $34.7K | $4.4M | $4.6M | $13.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $5.2M | $10.7M | $7.2M | $15.9M | |
Other Inc / (Exp) | $12.7M | -$12.3M | -$14.5M | $234K | -$8.2M | |
Operating Expenses | -- | $6.7M | $14.1M | $11.4M | $32.1M | |
Operating Income | -- | -$6.7M | -$9.7M | -$6.8M | -$18.2M | |
Net Interest Expenses | $152.8K | $431.1K | $2.6M | $3.2M | $5.5M | |
EBT. Incl. Unusual Items | -- | -$19.4M | -$26.8M | -$9.8M | -$31.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -$2.1M | -$4.4M | $92.7K | $126.1K | |
Net Income to Company | -- | -$17.4M | -$22.3M | -$9.9M | -$32M | |
Minority Interest in Earnings | $141.8K | $1.8M | $966.6K | -$157.6K | $4.1M | |
Net Income to Common Excl Extra Items | -- | -$15.6M | -$21.4M | -$10.1M | -$27.8M | |
Basic EPS (Cont. Ops) | -- | -$1.29 | -$1.32 | -$0.49 | -$0.91 | |
Diluted EPS (Cont. Ops) | -- | -$1.29 | -$1.32 | -$0.49 | -$0.91 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -$17.5M | -$20.8M | -$2.4M | -$10.1M | |
EBIT | -- | -$19M | -$24.1M | -$6.6M | -$26.3M | |
Revenue (Reported) | -- | -- | -- | $59.8M | $111.1M | |
Operating Income (Reported) | -- | -$6.7M | -$9.7M | -$6.8M | -$18.2M | |
Operating Income (Adjusted) | -- | -$19M | -$24.1M | -$6.6M | -$26.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $95K | -- | $15.5M | $16M | $37.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $91.9K | -- | $14M | $15M | $32.6M | |
Gross Profit | $3.1K | -- | $1.5M | $1.1M | $4.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.8M | $1.5M | $1.9M | $1.7M | $5.4M | |
Other Inc / (Exp) | $12.7M | $1.2M | -$485.8K | $148.9K | $67.4K | |
Operating Expenses | $2.1M | $1.9M | $2.6M | $2.7M | $11.2M | |
Operating Income | -$2.1M | -$1.9M | -$1.1M | -$1.6M | -$6.4M | |
Net Interest Expenses | $152.8K | $85.6K | $1.2M | $441.7K | $1.2M | |
EBT. Incl. Unusual Items | $10.4M | -$725.2K | -$2.8M | -$1.9M | -$7.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1M | $800 | $800 | $800 | -- | |
Net Income to Company | $9.4M | -$726K | -$2.8M | -$1.9M | -$7.5M | |
Minority Interest in Earnings | $141.8K | $125.2K | $282.6K | $28.3K | $6.5K | |
Net Income to Common Excl Extra Items | $9.5M | -$600.9K | -$2.5M | -$1.9M | -$7.5M | |
Basic EPS (Cont. Ops) | $0.84 | -$0.04 | -$0.14 | -$0.07 | -$0.21 | |
Diluted EPS (Cont. Ops) | $0.73 | -$0.04 | -$0.14 | -$0.07 | -$0.21 | |
Weighted Average Basic Share | $11.3M | $13.7M | $18.1M | $26.4M | $43.1M | |
Weighted Average Diluted Share | $13.1M | $13.7M | $18.1M | $26.4M | $43.1M | |
EBITDA | $10.9M | -$258.1K | -$826.2K | -$456.7K | -$518K | |
EBIT | $10.5M | -$633.3K | -$1.6M | -$1.5M | -$6.3M | |
Revenue (Reported) | $95K | -- | $15.5M | $16M | $37.3M | |
Operating Income (Reported) | -$2.1M | -$1.9M | -$1.1M | -$1.6M | -$6.4M | |
Operating Income (Adjusted) | $10.5M | -$633.3K | -$1.6M | -$1.5M | -$6.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $398.9K | $1.5M | $3.2M | $744.3K | $651K | |
Short Term Investments | $4M | $2.2M | $1.7M | $495.8K | $661.1K | |
Accounts Receivable, Net | $7.7K | $850 | $2.6M | $2.5M | $1.6M | |
Inventory | $1.7M | $1.4M | $47.2K | $44.6K | $205.5K | |
Prepaid Expenses | $87.1K | $73.3K | $731.8K | $1.2M | $1.2M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $6.2M | $5.2M | $9.2M | $5.1M | $12M | |
Property Plant And Equipment | $19M | $25.4M | $24.5M | $25.8M | $105M | |
Long-Term Investments | $4K | $4K | $4K | $4K | -- | |
Goodwill | -- | -- | $12.7M | $15M | $68.9M | |
Other Intangibles | $17M | $16M | $30M | $25.1M | $51.4M | |
Other Long-Term Assets | -- | -- | -- | $4K | $3.6M | |
Total Assets | $42.3M | $47.7M | $76.3M | $71.2M | $241M | |
Accounts Payable | $1M | $1.5M | $910K | $5.2M | $27.7M | |
Accrued Expenses | -- | -- | $1.8M | $1.6M | $5.9M | |
Current Portion Of Long-Term Debt | $1.9M | $4.9M | $2.8M | $18.1M | $61.1M | |
Current Portion Of Capital Lease Obligations | $276.7K | $287.8K | $1.4M | $1.4M | $6.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $3.6M | $7.2M | $12.9M | $40M | $113.5M | |
Long-Term Debt | $5.9M | $7.4M | $32.6M | $10.9M | $4.9M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $16.3M | $20.2M | $49.3M | $54M | $125.9M | |
Common Stock | $9.4M | $12.4K | $18.1K | $26.2K | $41.8K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $15.4M | $22.5M | $18.9M | $17.2M | $119.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $1.3M | $5M | $8.2M | $41.8K | -$4.1M | |
Total Equity | $26M | $27.6M | $27.1M | $17.2M | $115.1M | |
Total Liabilities and Equity | $42.3M | $47.7M | $76.3M | $71.2M | $241M | |
Cash and Short Terms | $4.4M | $3.7M | $4.8M | $1.2M | $1.3M | |
Total Debt | $7.8M | $12.3M | $35.4M | $29M | $66M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $6.8M | $2.7M | $767.3K | $765.4K | |
Short Term Investments | -- | $3.5M | $1.2M | $413.2K | $2.3M | |
Accounts Receivable, Net | -- | $850 | $2.2M | $4M | $12.9M | |
Inventory | -- | $1.4M | $70K | $57.8K | $132.3K | |
Prepaid Expenses | -- | $75.7K | $861.5K | $1.4M | $3.9M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | $11.8M | $7.2M | $6.8M | $28.5M | |
Property Plant And Equipment | -- | $26.2M | $25.6M | $28M | $98.9M | |
Long-Term Investments | -- | $4K | $4K | $4K | -- | |
Goodwill | -- | -- | $12.7M | $15M | $68.9M | |
Other Intangibles | -- | $15.7M | $29.3M | $24.4M | $48.2M | |
Other Long-Term Assets | -- | -- | -- | -- | $3.5M | |
Total Assets | -- | $54.8M | $74.7M | $74.4M | $248.2M | |
Accounts Payable | -- | $2.2M | $3M | $5.4M | $41.8M | |
Accrued Expenses | -- | -- | $2.9M | $1.7M | $1.1M | |
Current Portion Of Long-Term Debt | -- | $2.7M | $4.4M | $20.4M | $42.6M | |
Current Portion Of Capital Lease Obligations | -- | $270.5K | $1.5M | $1M | $6.7M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | $5.1M | $13.6M | $43.8M | $127.4M | |
Long-Term Debt | -- | $7.5M | $32.9M | $11.4M | $5.9M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $18.3M | $50.1M | $58.5M | $139.4M | |
Common Stock | -- | $15K | $18.1K | $26.5K | $45.1K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | $6.7M | $8.3M | $13.5K | -$4.1M | |
Total Equity | -- | $36.5M | $24.7M | $15.9M | $108.8M | |
Total Liabilities and Equity | -- | $54.8M | $74.7M | $74.4M | $248.2M | |
Cash and Short Terms | -- | $10.3M | $3.9M | $1.2M | $3.1M | |
Total Debt | -- | $10.1M | $37.3M | $31.8M | $70.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$2.9M | -$7.3M | -$20.2M | -$10.8M | -$26.4M | |
Depreciation & Amoritzation | $1.6M | $1.5M | $3M | $3.9M | $11.4M | |
Stock-Based Compensation | $146.1K | $446.1K | $2.6M | $1.6M | $2.6M | |
Change in Accounts Receivable | -$19.7K | $3.6K | $2.6M | $928.6K | -$5.1M | |
Change in Inventories | -- | -- | $162.2K | $2.6K | -$114.4K | |
Cash From Operations | -$1.8M | -$2.9M | -$4.1M | -$764.9K | $1.8M | |
Capital Expenditures | $1.2M | $4.5M | $2.5M | $3.3M | $4.5M | |
Cash Acquisitions | -- | -- | -- | -$181.1K | -- | |
Cash From Investing | -$1.2M | -$4.5M | -$2.3M | -$3.7M | $302.2K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2.2M | $9.1M | $3.6M | $3M | $7.5M | |
Long-Term Debt Repaid | -$122.9K | -$569.8K | -$853.2K | -$916.9K | -$8.1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $624.9K | -$55.1K | -$861.7K | -- | -- | |
Cash From Financing | $2.8M | $8.5M | $8.2M | $2M | $819.7K | |
Beginning Cash (CF) | $604.9K | $398.9K | $1.5M | $3.2M | $744.3K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$206K | $1.1M | $1.7M | -$2.4M | $2.9M | |
Ending Cash (CF) | $398.9K | $1.5M | $3.2M | $744.3K | $3.7M | |
Levered Free Cash Flow | -$3M | -$7.4M | -$6.6M | -$4.1M | -$2.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $9.4M | -$726K | -$2.8M | -$1.9M | -$7.5M | |
Depreciation & Amoritzation | $363.3K | $375.2K | $784.5K | $1M | $5.8M | |
Stock-Based Compensation | $111.5K | $111.5K | -- | $328K | $801.4K | |
Change in Accounts Receivable | -$92.3K | -$6.4K | $1.2M | -$1.6M | -$11.2M | |
Change in Inventories | -- | -$30K | -$22.8K | -$13.2K | $73.2K | |
Cash From Operations | -$1.3M | -$866.8K | -$1.3M | -$1.8M | -$40 | |
Capital Expenditures | $457.3K | $206.3K | $883.8K | $1M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$457.3K | -$196.3K | -$883.8K | -$1M | $1.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $3.3M | $427.5K | $2.3M | $3M | $6.3M | |
Long-Term Debt Repaid | -$1.5K | -$115K | -$367.7K | -$120.7K | -$6.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$136K | -$289K | -- | -- | |
Cash From Financing | $3.2M | $6.4M | $1.7M | $2.9M | -$370.2K | |
Beginning Cash (CF) | $398.9K | $1.5M | $3.2M | $744.3K | $3.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.5M | $5.4M | -$482.9K | $23K | $1.1M | |
Ending Cash (CF) | $1.9M | $6.8M | $2.7M | $767.3K | $4.8M | |
Levered Free Cash Flow | -$1.7M | -$1.1M | -$2.2M | -$2.9M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$17.4M | -$22.3M | -$9.9M | -$32M | |
Depreciation & Amoritzation | -- | $1.5M | $3.4M | $4.2M | $16.2M | |
Stock-Based Compensation | $111.5K | $446.1K | $2.5M | $1.9M | $3M | |
Change in Accounts Receivable | -- | $89.5K | $3.8M | -$1.8M | -$14.8M | |
Change in Inventories | -- | -$30K | $169.3K | $12.2K | -$28K | |
Cash From Operations | -- | -$2.5M | -$4.6M | -$1.3M | $3.6M | |
Capital Expenditures | $457.3K | $4.3M | $3.2M | $3.5M | $3.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$4.3M | -$3M | -$3.9M | $2.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $6.3M | $5.5M | $3.6M | $10.8M | |
Long-Term Debt Repaid | -- | -$683.3K | -$1.1M | -$669.9K | -$14.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$1M | -- | -- | |
Cash From Financing | -- | $11.7M | $3.4M | $3.2M | -$2.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $4.9M | -$4.1M | -$1.9M | $4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -$6.7M | -$7.7M | -$4.8M | $3.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $9.4M | -$726K | -$2.8M | -$1.9M | -$7.5M | |
Depreciation & Amoritzation | $363.3K | $375.2K | $784.5K | $1M | $5.8M | |
Stock-Based Compensation | $111.5K | $111.5K | -- | $328K | $801.4K | |
Change in Accounts Receivable | -$92.3K | -$6.4K | $1.2M | -$1.6M | -$11.2M | |
Change in Inventories | -- | -$30K | -$22.8K | -$13.2K | $73.2K | |
Cash From Operations | -$1.3M | -$866.8K | -$1.3M | -$1.8M | -$40 | |
Capital Expenditures | $457.3K | $206.3K | $883.8K | $1M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$457.3K | -$196.3K | -$883.8K | -$1M | $1.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $3.3M | $427.5K | $2.3M | $3M | $6.3M | |
Long-Term Debt Repaid | -$1.5K | -$115K | -$367.7K | -$120.7K | -$6.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$136K | -$289K | -- | -- | |
Cash From Financing | $3.2M | $6.4M | $1.7M | $2.9M | -$370.2K | |
Beginning Cash (CF) | $398.9K | $1.5M | $3.2M | $744.3K | $3.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.5M | $5.4M | -$482.9K | $23K | $1.1M | |
Ending Cash (CF) | $1.9M | $6.8M | $2.7M | $767.3K | $4.8M | |
Levered Free Cash Flow | -$1.7M | -$1.1M | -$2.2M | -$2.9M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.